Gluconorm SR 500mg Tablet is a medication primarily prescribed to manage type 2 diabetes mellitus. It effectively helps to control blood sugar levels, which is crucial in preventing the serious long-term complications associated with diabetes. This medicine contains Metformin 500mg, an active ingredient that aids in improving the body's response to insulin. Additionally, Gluconorm SR 500mg Tablet is also used in women to treat Polycystic ovary syndrome (PCOS), a common hormonal disorder related to menstruation.

For best results and to minimize stomach upset like nausea or abdominal pain, Gluconorm SR 500mg Tablet should be taken with food. It is vital to take this medicine regularly at the same time each day, as directed by your doctor, to achieve its maximum benefits. Do not stop taking Gluconorm SR 500mg Tablet without consulting your doctor. Managing type 2 diabetes relies significantly on lifestyle changes; therefore, maintaining the diet and exercise program recommended by your doctor is equally important while on this medication.

Common side effects of Gluconorm SR 500mg Tablet may include diarrhea, nausea, vomiting, flatulence, weakness, indigestion, abdominal discomfort, headache, and loss of appetite. It's important to note that some individuals may experience hypoglycemia (low blood sugar level) if this medicine is taken alongside other antidiabetic medications, consumed with alcohol, or if a meal is skipped. Regular monitoring of your blood sugar levels is recommended while taking Gluconorm SR 500mg Tablet.

Before starting treatment with Gluconorm SR 500mg Tablet, inform your doctor about any existing kidney, liver, or heart conditions. Pregnant or breastfeeding women should also seek medical advice before using this medication. Your doctor will typically perform kidney function tests before prescribing Gluconorm SR 500mg Tablet. It is advisable to avoid excessive alcohol intake during treatment as it may increase the risk of certain side effects, including a serious condition called lactic acidosis.

'